When you’ve tried antidepressants, therapy, and countless other approaches without real relief, it’s natural to feel frustrated. You might’ve heard about ketamine treatments and Spravato for treatment-resistant depression, but figuring out which one fits your needs can feel overwhelming. At Resilience Integrative Wellness, we’ve guided hundreds of San Diego patients through this exact decision, helping them understand how these innovative treatments differ and which might work best for their unique situation.
Both Spravato vs ketamine San Diego treatments offer hope when traditional approaches haven’t worked, but they’re not identical. Each has distinct benefits, administration methods, and insurance considerations. Let’s break down what you need to know to make an informed choice about your mental health care.
Understanding the Basics: What Are Ketamine and Spravato?
Before you can decide between these treatments, it helps to understand what they actually are. Ketamine has been used as an anesthetic since the 1970s, but researchers discovered something remarkable over the past two decades. This medication can rapidly reduce depression symptoms, often within hours, by targeting the brain’s NMDA receptors in a completely different way than traditional antidepressants.
Here’s where things get interesting. Ketamine exists as two mirror-image molecules called enantiomers. The racemic form, which is what you get with IV ketamine therapy in San Diego, contains both molecules. Spravato, on the other hand, contains only the S-enantiomer, known as esketamine. Think of it like how your left and right hands are similar but not identical. They’re related but have different properties.
IV ketamine therapy delivers the medication directly into your bloodstream through an intravenous infusion. You’ll sit comfortably in a treatment room while the solution drips slowly over about 40 minutes. The direct route to your bloodstream means faster absorption and the ability to adjust dosing precisely for your needs.
Spravato takes a completely different approach. Developed by Janssen Pharmaceuticals, it’s administered as a nasal spray you use under medical supervision. You’ll spray the medication into each nostril yourself, following guidance from your treatment team. The FDA specifically approved Spravato for treatment-resistant depression in adults, which means it’s gone through rigorous clinical trials to prove its effectiveness.
Both treatments work on your brain’s glutamate system rather than the serotonin or dopamine systems targeted by traditional antidepressants. This explains why they can help when other medications haven’t. But the similarities largely end there.
How Administration Methods Differ Between Spravato and IV Ketamine
The way you receive these treatments couldn’t be more different, and this matters more than you might think. With IV ketamine therapy, a trained clinician inserts a small IV catheter into your arm, similar to what you’d experience during routine blood work. The ketamine solution flows directly into your vein over the course of your session, typically lasting 40 to 60 minutes depending on your protocol.
You’ll need to stay at our San Diego clinic for monitoring after your infusion. Most patients remain for about 90 minutes to two hours total. During this time, you might experience a gentle dissociative state, where thoughts and feelings become less intense. Many patients describe this as peaceful or meditative. You’re awake and aware but in an altered state that some find therapeutic in itself.
Spravato treatment in San Diego follows a different protocol entirely. You’ll use the nasal spray device yourself, with your clinician present to guide you. The device is pre-measured, so you don’t need to worry about dosing accuracy. You’ll spray once in each nostril, wait five minutes, then repeat the process. The entire administration takes about 20 minutes.
After using Spravato, you’ll remain under observation for at least two hours. This monitoring period isn’t optional. It’s required by the FDA’s Risk Evaluation and Mitigation Strategy because of potential side effects like sedation, dissociation, and blood pressure changes. You can’t skip this step, even if you’re feeling fine.
Neither treatment allows you to drive yourself home afterward. You’ll need to arrange transportation with a friend, family member, or ride service. This requirement continues throughout your entire treatment course, whether that’s weeks or months. Plan accordingly when scheduling your sessions.
FDA Approval Status and Insurance Coverage Considerations
This is where Spravato and IV ketamine diverge significantly, and it directly impacts your wallet. Spravato received FDA approval specifically for treatment-resistant depression in 2019. This approval came after extensive clinical trials demonstrated its safety and effectiveness. Because it’s FDA-approved for this indication, most insurance plans will cover Spravato treatment if you meet specific criteria.
What criteria? Generally, you need to have tried at least two different antidepressant medications without adequate response. Your insurance company will likely require documentation of these failed attempts. But once you’re approved, your out-of-pocket costs may be minimal compared to paying privately. Some patients pay only a copay, while others might have a deductible to meet first.
IV ketamine therapy operates in what’s called the “off-label” space. The FDA approved ketamine as an anesthetic decades ago, but using it for depression is considered an off-label application. This doesn’t mean it’s unsafe or ineffective. In fact, off-label prescribing is common in medicine. However, it does mean insurance companies typically won’t cover IV ketamine for depression treatment.
You’ll likely pay out of pocket for IV ketamine sessions in San Diego. Costs vary between clinics, but expect to invest several hundred dollars per infusion. Most treatment protocols start with six infusions over two to three weeks, so the initial investment can be substantial. Some patients find the benefits worth every penny, but it’s important to budget accordingly.
There’s an interesting twist here. While Spravato may seem like the obvious choice financially, the story isn’t quite that simple. The required observation time, frequency of visits, and additional monitoring can mean more time away from work or family commitments. IV ketamine often requires fewer total visits to achieve results, which might offset some cost differences for certain patients.
Treatment Protocols: Frequency and Duration
When you’re choosing between these treatments, understanding the time commitment is crucial. They follow quite different schedules, and one might fit your life better than the other.
IV ketamine therapy typically starts with an induction phase of six infusions over two to three weeks. You might come twice a week initially, then transition to weekly or monthly maintenance infusions depending on your response. Some patients find they need boosters every few weeks, while others go months between treatments. The flexibility allows your treatment team to personalize your schedule based on how you’re responding.
Spravato follows a more rigid protocol, at least initially. During your induction phase, you’ll come twice weekly for the first four weeks. That’s eight visits in your first month. Then you’ll transition to once-weekly treatments for weeks five through eight. After that, you move to either weekly or every-other-week maintenance, depending on your symptoms and response.
This structured schedule exists because that’s how the FDA approval studies were conducted. Insurance companies generally require following this protocol to maintain coverage. You can’t skip sessions or space them out more than recommended without potentially losing insurance approval.
Think about your schedule honestly. Can you commit to twice-weekly appointments for a month? Do you have reliable transportation for each visit? Can you take the time off work, especially considering you can’t drive afterward? These aren’t small considerations when you’re already dealing with depression.
The duration of each session differs too. IV ketamine infusions typically take 40 to 60 minutes for the actual infusion, plus monitoring time. Your total clinic visit might run two to three hours. Spravato administration takes about 20 minutes, but the mandatory two-hour observation period means you’re looking at roughly 2.5 hours per visit.
Neither treatment is a one-and-done solution. Both require ongoing maintenance for most patients. Depression isn’t cured by a few treatments. These therapies help manage symptoms, often dramatically, but they work best as part of a comprehensive treatment plan that might include traditional therapy, lifestyle changes, and ongoing medical support.
Clinical Evidence and Success Rates
You deserve to know what the research actually shows. Both treatments have solid evidence backing their use, but the studies differ in scope and design.
Spravato’s clinical trials were rigorous, double-blind, placebo-controlled studies. These are the gold standard in research. Results showed that patients receiving Spravato alongside an oral antidepressant experienced significantly better symptom reduction compared to those getting a placebo nasal spray plus an antidepressant. About 70% of participants showed meaningful improvement.
Long-term studies found that patients who continued Spravato treatment were less likely to relapse compared to those who stopped. This suggests sustained benefits with ongoing treatment. The research specifically focused on treatment-resistant depression, meaning patients had already failed multiple antidepressant trials.
IV ketamine research is extensive but mostly exists outside the formal FDA approval process. Studies consistently show response rates of 60% to 80%, with many patients experiencing relief within hours or days. Research published in the American Journal of Psychiatry and other respected journals demonstrates ketamine’s effectiveness for treatment-resistant depression, suicidal ideation, and even PTSD.
One advantage of IV ketamine is the ability to adjust dosing precisely. Your clinician can increase or decrease the infusion rate, modify the total dose, or extend the infusion time based on your individual response. This personalization isn’t possible with Spravato’s pre-measured nasal spray devices.
However, most IV ketamine studies have smaller sample sizes than Spravato’s FDA trials. This doesn’t invalidate the research, but it means we’re still learning about optimal protocols, long-term outcomes, and which patients benefit most.
Both treatments show particular promise for patients with suicidal thoughts. Research indicates rapid reduction in suicidal ideation, sometimes within hours. This life-saving potential makes these treatments especially valuable for patients in crisis, though they should always be part of comprehensive suicide prevention planning.
Side Effects and Safety Profiles
Understanding potential side effects helps you prepare mentally and practically for treatment. Both medications affect your brain in similar ways, so they share some common effects.
During IV ketamine infusions, you’ll likely experience dissociation. This altered state might feel dreamlike or as if you’re floating. Some patients find it pleasant and therapeutic, while others find it uncomfortable. Colors might seem more vivid, thoughts might feel disconnected, and time perception often shifts. These effects typically resolve within an hour or two after your infusion ends.
Spravato causes similar dissociative effects, though the nasal spray route may produce slightly different intensity or duration. You might also experience nasal discomfort, a bad taste, nausea, or dizziness. These effects usually fade during the observation period, which is why that two-hour monitoring window exists.
Both treatments can temporarily increase blood pressure and heart rate. Your medical team will monitor these vital signs throughout your session and recovery period. Patients with uncontrolled high blood pressure or certain heart conditions may not be suitable candidates for either treatment.
Some patients report feeling fatigued or “out of it” for several hours after treatment. This is why driving isn’t permitted. You’ll want to clear your schedule for the rest of the day rather than planning to return to work or handle important responsibilities.
Long-term effects remain an area of ongoing research. Some concerns exist about potential bladder effects with chronic ketamine use, though this has primarily been seen in recreational users taking much higher doses. Both treatments require ongoing monitoring to catch any developing issues early.
At Resilience Integrative Wellness, we take safety seriously. Our veteran-owned clinic has over 60 years of combined medical experience on our team. We carefully screen all patients, monitor vital signs throughout treatment, and provide comfortable, private treatment rooms where you can relax during your session.
Who Is the Ideal Candidate for Each Treatment?
Not everyone is suited for these treatments, and even among good candidates, one option may fit better than another. Let’s break down who typically does well with each approach.
You might be an ideal Spravato candidate if you have insurance coverage that will pay for treatment, can commit to the required twice-weekly visits initially, and need FDA-approved treatment for employment or personal reasons. Spravato works well for patients who prefer not having an IV placed or who want the reassurance of a medication specifically approved for their condition.
IV ketamine often suits patients who’ve tried Spravato without sufficient results, who don’t have insurance coverage anyway, or who prefer the flexibility of adjustable dosing. Some patients find the slightly different effects of racemic ketamine more helpful than esketamine alone. The ability to modify your dose and infusion time provides personalization that Spravato’s pre-measured spray can’t match.
Both treatments require that you’ve already tried traditional antidepressants without success. We’re talking about genuine treatment-resistant depression here, not first-line therapy. Your psychiatrist or primary care provider should have documented at least two failed antidepressant trials before considering these options.
Certain medical conditions may make one treatment preferable. If you have chronic sinus issues or nasal problems, the nasal spray might not work well. If you’re difficult to access with IVs or have a strong aversion to needles, the nasal route might be better.
Your lifestyle matters too. The rigid Spravato schedule works for some but not others. If you travel frequently for work or have unpredictable commitments, IV ketamine’s more flexible maintenance schedule might fit better. On the other hand, if you thrive with structure and consistency, Spravato’s defined protocol might feel reassuring.
Making Your Decision: Factors to Consider
Choosing between Spravato and IV ketamine isn’t always straightforward. Several practical and personal factors should influence your decision.
Start with insurance. Call your insurance company and ask specifically about Spravato coverage. Find out what documentation you’ll need, whether pre-authorization is required, and what your out-of-pocket costs will be. Then price out IV ketamine options in San Diego for comparison. The financial difference might be significant enough to heavily weight your decision one way.
Consider your schedule realistically. Can you commit to twice-weekly appointments for a month, then weekly for another month? Do you have reliable transportation for each visit? What impact will taking several hours off twice a week have on your work or family life?
Think about your treatment history. Have you tried multiple antidepressants without success? Are you currently on a medication that’s partially helping but not enough? Your current antidepressant situation matters because Spravato is designed to work alongside continued antidepressant use, while IV ketamine can work as a standalone treatment.
Your personal preferences count. Some patients want the FDA’s specific stamp of approval. Others prioritize treatment flexibility and personalization. Neither perspective is wrong. This is your mental health care, and you deserve treatment that feels right to you.
Don’t forget about additional support services. At our San Diego clinic, we offer comprehensive care beyond just medication administration. We can integrate your ketamine or Spravato treatment with other approaches like TMS therapy if needed. Having a treatment team that sees the whole picture of your mental health makes a real difference in outcomes.
Why Choose Resilience Integrative Wellness for Your Treatment?
When you’re making such an important decision about your mental health, the clinic you choose matters as much as which treatment you select. Here’s what sets Resilience Integrative Wellness apart in San Diego.
We’re a veteran-owned practice with deep roots in the San Diego community. Our location at 6719 Alvarado Road, Suite 201, provides easy access for patients throughout the San Diego area. But it’s not just about convenience. Our team brings over 60 years of combined medical experience to your care.
We offer both Spravato and IV ketamine therapy, which means we’re not biased toward one treatment over the other. Some clinics only provide one option, which can skew the advice you receive. We’ll honestly assess which treatment fits your situation best, even if that means recommending you try the other option first.
Our success rate speaks for itself. About 80% of our ketamine therapy patients experience significant improvement. We’ve helped veterans, first responders, and civilians throughout San Diego find relief when other treatments failed. Our testimonials reflect the life-changing results patients experience in our care.
The environment matters when you’re receiving these treatments. We’ve created spa-like treatment suites where you can relax comfortably during your session. You’ll have privacy, soft lighting, noise-canceling headphones, curated playlists, and everything you need to make your experience as pleasant as possible.
We don’t just administer medication and send you on your way. Our team provides comprehensive support throughout your treatment journey. We’ll help you understand what to expect, monitor your progress carefully, adjust your protocol as needed, and connect you with additional resources if helpful.
Take the Next Step Toward Relief
You’ve tried traditional treatments. You’ve waited for antidepressants to work. You’ve given therapy a genuine effort. But you’re still struggling, and that’s not your fault. Treatment-resistant depression is a real medical condition, and you deserve treatment that actually works.
Both Spravato and IV ketamine offer hope when conventional approaches haven’t helped. The research supports both treatments. Patients throughout San Diego are experiencing relief after years of struggling. The question isn’t whether these treatments work, but which one is right for you.
The only way to know for sure is to talk with someone who understands both options thoroughly. At Resilience Integrative Wellness, we’re here to help you make this decision based on your unique needs, circumstances, and goals.
Call us today at (619) 768-8723 to schedule your complimentary consultation. We’ll review your medical history, discuss your treatment goals, and help you understand which approach makes the most sense for your situation. You can also visit our website at resilienceintegrative.com to learn more about our services and approach.
You don’t have to keep suffering. Relief is possible, and we’re here to help you find it. Whether that’s through Spravato, IV ketamine, or another innovative treatment, we’ll work together to develop a plan that finally brings you the mental health improvement you deserve.
Take that first step today. Your future self will thank you.
Resilience Integrative Wellness
6719 Alvarado Road, Suite 201
San Diego, CA 92120
Phone: (619) 768-8723
Schedule Your Free Consultation
The information on this page is for educational purposes only and does not constitute medical advice. Individual results may vary. Always consult with a qualified healthcare provider before beginning any new treatment.
